Psychiatry Rounds in Substance Use Disorder: Adopting Effective Management Strategies for Improved Patient Outcomes

Psychiatry Rounds in Substance Use Disorder: Adopting Effective Management Strategies for Improved Patient Outcomes

On-Demand Webcast
Faculty

Thomas Kosten, MD
JH Waggoner Professor of Psychiatry,
Baylor College of Medicine
Director, Institute of Clinical and
Translation Research
Houston, Texas

Intended Learners

This activity is designed for psychiatrists, psychiatry fellows, psychiatry residents, and psychiatric-focused NPs, PAs, nurses, and other related mental healthcare practitioners.

Learning Objectives

After completing this activity, participants should be able to:

  • Identify risks for and signs and symptoms of substance use disorder (SUD)
  • Describe the benefits and limitations of available and emerging therapies for opioid use disorder and alcohol use disorder treatment
  • Address patient and physician-centric barriers, such as treatment adherence and inadequate adoption of effective pharmacotherapy, within the individualized care of patients with SUD
  • Develop concurrent treatment strategies for the dual management of SUDs and co-existing psychiatric disorders
Activity Overview

This on-demand webcast is available with synchronized slides and video.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Release Date: August 30, 2016
Expiration Date: August 30, 2017
Estimated time to complete: 1 hour

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs (please download here). A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation

  In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CME

NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

CNE

This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

Nurse practitioners participating in this educational activity will earn an AMA PRA Category 1 Credit™ certificate of completion or ANCC contact hours through AANP’s reciprocity agreements.

APA CE Information

North American Center for Continuing Medical Education, LLC (NACCME) is approved by the American Psychological Association to sponsor continuing education for psychologists. NACCME maintains responsibility for this program and its content.

Instructional Level: Advanced
For faculty bios, please call 609-371-1137.

Independent Clinical Reviewer: William C. Torrey, MD, Professor of Psychiatry, Dartmouth’s Geisel School of Medicine, Vice Chair for Clinical Services, Dartmouth-Hitchcock, Lebanon, New Hampshire

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Planning Committee

The planning committee comprises Thomas Kosten, MD, Susie Seaman, NP, and William C. Torrey, MD; Donna Brophy, Kristin Ciszeski, Jennifer Ilcyn, Mary Johnson, Mike Kearney, Laura Parise, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Kosten: Grant/research support—Alkermes; Consultant--Indivior, US World Pharma; Stock shareholder—Biotie
Ms. Seaman: Scientific Advisor—Smith & Nephew; Promotional Speakers’ Bureau—Smith & Nephew

Dr. Torrey has disclosed no relevant financial relationships with any commercial interests.

Ms. Brophy, Ms. Ciszeski, Ms. Ilcyn, Ms. Johnson, Mr. Kearney, Ms. Parise, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that the following off-label/unapproved uses of drugs and/or devices will be discussed: lofexidine and cocaine vaccine in substance use disorder.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2016 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by unrestricted educational grants from Alkermes, Inc., Braeburn Pharmaceuticals, Inc., and Indivior Inc.